Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission
Editorial Group: Cochrane Haematological Malignancies Group
Published Online: 12 DEC 2012
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Mao C, Huang YF, Yang ZY, YE QL, Wu XY, Hu XF, Zhai ZM, Tang JL. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010248. DOI: 10.1002/14651858.CD010248.
- Publication Status: New
- Published Online: 12 DEC 2012
This is the protocol for a review and there is no abstract. The objectives are as follows:
The primary objective of this study will be to evaluate the efficacy of interleukin-2 (IL-2) as maintenance therapy in patients with acute myeloid leukaemia (AML) who have achieved first complete remission (CR).